Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cooling cap may save hair for black women on chemo

NCT ID NCT07201389

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 27 times

Summary

This study tests whether the DigniCap scalp cooling system can prevent chemotherapy-induced hair loss in Black patients with early-stage breast cancer. About 30 participants will use the cooling cap during at least four cycles of taxane or anthracycline-based chemo. The goal is to see if most patients keep enough hair to avoid needing a wig.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • George Washington-Medical Faculty Associates

    Washington D.C., District of Columbia, 20037, United States

Conditions

Explore the condition pages connected to this study.